Lercanidipine Rescues Hippocampus Pyramidal Neurons from Mild Ischemia-Induced Delayed Neuronal Death in SHRSP
Tóm tắt
Stroke-prone spontaneously hypertensive rats (SHRSPs) are vulnerable to ischemia and delayed neuronal death (DND) of hippocampus pyramidal cells when bilateral carotid arteries are occluded for only 10 min. Since this occlusion induces just mild ischemia, the resulting DND may be an appropriate animal model for dementia in patient with essential hypertension exposed to small ischemic insults. This study was designed to compare the effects of the antihypertensive drugs lercanidipine, nicardipine, lisinopril, valsartan, and hydralazine on occlusion-induced DND in SHRSPs. Drugs were administered for 2 weeks, from 15 to 17 weeks of age. 0.1% Nicardipine and 0.01 or 0.03% lercanidipine were administered in the SP diet (about 61.3, 5.7, and 18.8 mg/kg/day, respectively), and the remaining drugs were administered at 10 mg/kg/day using the mini-osmotic pump. The animals were operated on at 16 weeks of age, and DND was analyzed by histological examination 1 week later. Systolic blood pressure was measured at 15, 16, and 17 weeks of age. For chronic treatment, Calcium-channel blockers were administered from 8 to 17 weeks of age. All antihypertensive drugs significantly lowered systolic blood pressure at 16 weeks of age. Hydralazine and lisinopril were associated with the greatest reduction; however, lercanidipine, nicardipine, and valsartan effectively reduced systolic blood pressure to within a medium range. DND was significantly inhibited only by 0.03% lercanidipine. Chronic treatment with 0.03% lercanidipine also protected pyramidal neurons. The results of this study demonstrate that the long-acting, lipophilic Calcium-channel blocker lercanidipine inhibits occlusion-induced DND in SHRSPs and that lercanidipine may effectively reduce dementia induced by small ischemic insults in patients with essential hypertension.
Tài liệu tham khảo
Angelico P, Guarneri L, Leonardi A, Testa R (1999) Vascular selective effect of lercanidipine and other 1,4-dihydropyridines in isolated rabbit tissues. J Pharm Pharmacol 51:709–714
Cai H, Yao H, Ibayashi S, Uchimura H, Fujishima M (1998) Photothrombotic middle cerebral artery occlusion in spontaneously hypertensive rats: influence of substrain, gender, and distal middle cerebral artery pattern on infarct size. Stroke 29:1986–1987
Carlos DM, Goto S, Urata Y, Iida T, Cho S, Niwa M, Tsuji Y, Kondo T (1998) Nicardipine normalizes elevated levels of antioxidant activity in response to xanthine oxidase-induced oxidative stress in hypertensive rat heart. Free Radic Res 29:143–150
Frishman WH (2002) Are antihypertensive agents protective against dementia? A review of clinical and preclinical data. Heart Dis. 4:380–386
Jeffs B, Clark JS, Anderson NH, Gratton J, Brosnan MJ, Gauguier D, Reid JL, Macrae IM, Dominiczak AF (1997) Sensitivity to cerebral ischaemic insult in a rat model of stroke is determined by a single genetic locus. Nat Genet 16:364–367
Kinugawa H, Sakurai-Yamashita Y, Niwa M (2008) Mild ischemia produces hippocampal neuronal death in stroke-prone spontaneously hypertensive rats. Brain Res 1229:204–209
Kirino T (1982) Delayed neuronal death in the gerbil hippocampus following ischemia. Brain Res 239:57–69
Kuriyama Y, Hashimoto H, Nagatsuka K, Sawada T, Omae T (1993) Effects of dihydropyridines on cerebral blood vessels. J Hypertens Suppl 1:S9–S12
Mackenzie IS, McEniery CM, Dhakam Z, Brown MJ, Cockcroft JR, Wilkinson IB (2009) Comparison of the effects of antihypertensive agents on central blood pressure and arterial stiffness in isolated systolic hypertension. Hypertension 54:409–413
Makarounas-Kirchmann K, Glover-Koudounas S, Ferrari P (2009) Results of a meta-analysis comparing the tolerability of lercanidipine and other dihydropyridine Calcium channel blockers. Clin Ther 31:1652–1663
Menne J, Park JK, Agrawal R, Lindschau C, Kielstein JT, Kirsch T, Marx A, Muller D, Bahlmann FH, Meier M, Bode-Böger SM, Haller H, Fliser D (2006) Cellular and molecular mechanisms of tissue protection by lipophilic calcium channel blockers. FASEB J 20:994–996
Niwa M, Shigematsu K, Maeda T, Fujimoto M, Yamashita K, Kataoka Y, Taniyama K (1994) Effects of MPC-1304, a novel calcium antagonist, on stroke-prone spontaneously hypertensive rats. Arch Int Pharmacodyn Ther 327:309–329
Okamoto K, Yamori Y, Nagaoka A (1974) Establishment of the stroke-prone spontaneously hypertensive rat (SHRSP). Circ Res 34:143–153
Paxinos G, Watson C (1986) The rat brain in stereotaxic coordinates. Academic Press, New York
Pulsinelli WA, Brierley JB, Plum F (1982) Temporal profile of neuronal damage in a model of transient forebrain ischemia. Ann Neurol 1:491–498
Qiang W-G, Ikeda K, Nara Y, Horie R, Yamori Y (1989) Delayed neuronal death by transient ligations of bilateral carotid arteries in SHRSR, SHRSP, and WKY. Jpn Heart J (Abst) 30:582
Sakurai-Yamashita Y, Yamashita K, Kataoka Y, Himeno A, Niwa M, Taniyama K (1997) Expression of endothelin receptors and nitric oxide synthase in the brain of stroke-prone spontaneously hypertensive rats with cerebral apoplexy. Brain Res 756:61–67
Sakurai-Yamashita Y, Yamashita K, Niwa M, Taniyama K (2003) Involvement of 5-hydroxytryptamine4 receptor in the exacerbation of neuronal loss by psychological stress in the hippocampus of SHRSP with a transient ischemia. Brain Res 973:92–98
Sakurai-Yamashita Y, Nabika T, Niwa M (2010) Blood pressure-independent factors determine the susceptibility to delayed neuronal death in the stroke-prone spontaneously hypertensive rats. Cell Mol Neurobiol 30:283–287
Staessen JA, Gasowski J, Wang JG, Thijs L, Den Hond E, Boissel JP, Coope J, Ekbom T, Gueyffier F, Liu L, Kerlikowske K, Pocock S, Fagard RH (2000) Risks of untreated and treated isolated systolic hypertension in the elderly: meta-analysis of outcome trials. Lancet 355:865–872
Tagami M, Yamagata K, Ikeda K, Nara Y, Fujino H, Kubota A, Numano F, Yamori Y (1998) Vitamin E prevents apoptosis in cortical neurons during hypoxia and oxygen reperfusion. Lab Invest 78:1415–1429
Takahara A, Konda T, Enomoto A, Kondo N (2004) Neuroprotective effects of dual L/N-type Ca channel blocker cilnidipine in the rat focal brain ischemia model. Biol Pharm Bull 27:1388–1391
Tisaire-Sánchez J, Roma J, Camacho-Azcargorta I, Bueno-Gómez J, Mora-Maciá J, Navarro A (2006) Assessment of cognitive function in patients with essential hypertension treated with lercanidipine. Vasc Health Risk Manag 2:491–498
Tsien RW, Lipscombe D, Madison D, Bley K, Fox A (1995) Reflections on Ca(2+)-channel diversity, 1988–1994. Trends Neurosci 18:52–54
Webb AJS, Fischer U, Mehta Z, Rothwell PM (2010) Effects of antihypertensive-drug class on inter-individual variation in blood pressure and risk of stroke: a systematic review and meta-analysis. Lancet 375:906–915
Yamashita K, Niwa M, Kataoka Y, Shigematsu K, Himeno A, Tsutsumi K, Nakano-Nakashima M, Sakurai-Yamashita Y, Shibata S, Taniyama K (1994) Microglia with an endothelin ETB receptor aggregate in rat hippocampus CA1 subfield following transient forebrain ischemia. J Neurochem 63:1042–1051